Suzanne Moreland - Concepedia

Author

Suzanne Moreland

Also Known As

Moreland, S., S Moreland, S. MORELAND, S. Moreland, SUZANNE MORELAND, Susan Moreland, Suzanne M. Moreland, Suzanne Moreland

Publications

4.6K

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Bristol-Myers Squibb (Germany)Bristol-Myers Squibb (Sweden)Institute for Medical Research Graduate Hospital

About

Suzanne Moreland is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacology, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	41	2.3K
2	Natural Sciences	11	12	887
3	Engineering	5	5	193
4	Health Sciences	2	2	88
5	Applied Physiology	1	1	25

Suzanne Moreland

Publications

4.3K

Citations

H-Index

Page 1

	Year	Citations
Dihydropyrimidine calcium channel blockers. 3. 3-Carbamoyl-4-aryl-1,2,3,4-tetrahydro-6-methyl-5-pyrimidinecarboxylic acid esters as orally effective antihypertensive agents Karnail S. Atwal, Brian N. Swanson, Steven E. Unger, Journal of Medicinal Chemistry	1991	782
Dihydropyrimidine calcium channel blockers. 4. Basic 3-substituted-4-aryl-1,4-dihydropyrimidine-5-carboxylic acid esters. Potent antihypertensive agents George C. Rovnyak, Karnail S. Atwal, Anders Hedberg, Journal of Medicinal Chemistry	1992	449
Dihydropyrimidine calcium channel blockers. II. 3-Substituted-4-aryl-1,4-dihydro-6-methyl-5-pyrimidinecarboxylic acid esters as potent mimics of dihydropyridines Karnail S. Atwal, George C. Rovnyak, S. David Kimball, Journal of Medicinal Chemistry Pharmaceutical ScienceBioorganic Chemistry3-Substituted-4-aryl-1,4-dihydro-6-methyl-5-pyrimidinecarboxylic Acid EstersAltmetric Attention ScoreOrganic Chemistry	1990	375
Dihydropyrimidine calcium channel blockers: 2-heterosubstituted 4-aryl-1,4-dihydro-6-methyl-5-pyrimidinecarboxylic acid esters as potent mimics of dihydropyridines Karnail S. Atwal, George C. Rovnyak, Joseph E. Schwartz, Journal of Medicinal Chemistry	1990	283
Venous smooth muscle contains vasoconstrictor ETB-like receptors Suzanne Moreland, Diane M. McMullen, Carol L. Delaney, Biochemical and Biophysical Research Communications Venous DiseaseMolecular PhysiologyEtb-like ReceptorsMedicineVascular Pharmacology	1992	256
Pharmacologic Profile of the Dihydropyrimidine Calcium Channel Blockers SQ 32,547 and SQ 32,946 Gary J. Grover, Steven Dzwonczyk, Diane M. McMullen, Journal of Cardiovascular Pharmacology Molecular PharmacologyCardiovascular DiseaseMedicinePhysiologySq 32,547	1995	256
The Discovery of Sulfonamide Endothelin Antagonists and the Development of the Orally Active ETA Antagonist 5-(Dimethylamino)-N-(3,4-dimethyl-5- isoxazolyl)-1-naphthalenesulfonamide Philip D. Stein, John T. Hunt, David Floyd, Journal of Medicinal Chemistry Pharmaceutical ScienceAltmetric Attention ScorePharmacotherapy3,4-Dimethyl-5- IsoxazolylChemical Biology	1994	137
Endothelin increases myofilament Ca2+ sensitivity in alpha-toxin-permeabilized rabbit mesenteric artery. Junji Nishimura, Suzanne Moreland, Hee-Yul Ahn, Circulation Research Vascular DiseaseEngineeringMuscle FunctionMicrom GtpCytoskeleton	1992	91
Endothelin-1 and angiotensin-II stimulate delayed mitogenesis in cultured rat aortic smooth muscle cells: evidence for common signaling mechanisms. H. Wéber, Maria L. Webb, R Serafino, Molecular Endocrinology Vasoactive PeptidesImmunologyCardiovascular FunctionCellular PhysiologyInflammation	1994	87
Synthesis and biological activity of novel calcium channel blockers: 2,5-dihydro-4-methyl-2-phenyl-1,5-benzothiazepine-3-carboxylic acid esters and 2,5-dihydro-4-methyl-2-phenyl-1,5-benzodiazepine-3-carboxylic acid esters Karnail S. Atwal, James L. Bergey, Anders Hedberg, Journal of Medicinal Chemistry	1987	75

Page 1